Scientific article

Human venous valve disease caused by mutations in FOXC2 and GJC2

Published inJournal of Experimental Medicine, vol. 214, no. 8, p. 2437-2452
Publication date2017

Venous valves (VVs) prevent venous hypertension and ulceration. We report that FOXC2 and GJC2 mutations are associated with reduced VV number and length. In mice, early VV formation is marked by elongation and reorientation ("organization") of Prox1(hi) endothelial cells by postnatal day 0. The expression of the transcription factors Foxc2 and Nfatc1 and the gap junction proteins Gjc2, Gja1, and Gja4 were temporospatially regulated during this process. Foxc2 and Nfatc1 were coexpressed at P0, and combined Foxc2 deletion with calcineurin-Nfat inhibition disrupted early Prox1(hi) endothelial organization, suggesting cooperative Foxc2-Nfatc1 patterning of these events. Genetic deletion of Gjc2, Gja4, or Gja1 also disrupted early VV Prox1(hi) endothelial organization at postnatal day 0, and this likely underlies the VV defects seen in patients with GJC2 mutations. Knockout of Gja4 or Gjc2 resulted in reduced proliferation of Prox1(hi) valve-forming cells. At later stages of blood flow, Foxc2 and calcineurin-Nfat signaling are each required for growth of the valve leaflets, whereas Foxc2 is not required for VV maintenance.

Citation (ISO format)
LYONS, Oliver et al. Human venous valve disease caused by mutations in FOXC2 and GJC2. In: Journal of Experimental Medicine, 2017, vol. 214, n° 8, p. 2437–2452. doi: 10.1084/jem.20160875
Main files (1)
Article (Published version)
ISSN of the journal0022-1007

Technical informations

Creation07/24/2017 10:40:00 AM
First validation07/24/2017 10:40:00 AM
Update time03/15/2023 2:19:04 AM
Status update03/15/2023 2:19:02 AM
Last indexation08/30/2023 5:11:05 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack